ANDA 40152, held by Watson Labs. Carisoprodol.
As of Nov 16, 2026, ANDA 40152 (Carisoprodol), held by Watson Labs, was first approved by FDA on Dec 3, 1996, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 3, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carisoprodol350MG ยท tablet;oral | Carisoprodol | Discontinued |
| Apr 12, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Mar 21, 2000 | Supplement 3Manufacturing | Approved | None posted |
| Jul 8, 1997 | Supplement 1Manufacturing | Approved | None posted |
| Dec 3, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters